Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Am J Kidney Dis ; 78(3): 380-390, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-33549627

RESUMO

RATIONALE & OBJECTIVE: Research on pediatric kidney replacement therapy (KRT) has primarily focused on Europe and North America. In this study, we describe the mortality risk of children treated with maintenance peritoneal dialysis (MPD) in different parts of the world and characterize the associated demographic and macroeconomic factors. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: Patients younger than 19 years at inclusion into the International Pediatric Peritoneal Dialysis Network registry, who initiated MPD between 1996 and 2017. EXPOSURE: Region as primary exposure (Asia, Western Europe, Eastern Europe, Latin America, North America, and Oceania). Other demographic, clinical, and macroeconomic (4 income groups based on gross national income) factors also were studied. OUTCOME: All-cause MPD mortality. ANALYTICAL APPROACH: Patients were observed for 3 years, and the mortality rates in different regions and income groups were calculated. Cause-specific hazards models with random effects were fit to calculate the proportional change in variance for factors that could explain variation in mortality rates. RESULTS: A total of 2,956 patients with a median age of 7.8 years at the start of KRT were included. After 3 years, the overall probability of death was 5%, ranging from 2% in North America to 9% in Eastern Europe. Mortality rates were higher in low-income countries than in high-income countries. Income category explained 50.1% of the variance in mortality risk between regions. Other explanatory factors included peritoneal dialysis modality at start (22.5%) and body mass index (11.1%). LIMITATIONS: The interpretation of interregional survival differences as found in this study may be hampered by selection bias. CONCLUSIONS: This study shows that the overall 3-year patient survival on pediatric MPD is high, and that country income is associated with patient survival.


Assuntos
Falência Renal Crônica/terapia , Diálise Peritoneal/métodos , Adolescente , Fatores Etários , Ásia/epidemiologia , Causas de Morte/tendências , Criança , Pré-Escolar , Europa (Continente)/epidemiologia , Feminino , Seguimentos , Humanos , Falência Renal Crônica/mortalidade , Masculino , América do Norte/epidemiologia , Estudos Prospectivos , Sistema de Registros , Taxa de Sobrevida/tendências , Fatores de Tempo
3.
Pediatr Nephrol ; 25(11): 2359-62, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20628764

RESUMO

Primary hyperoxaluria type 1 (PH-1) is a rare autosomal recessive disease caused by the absence or deficiency of the liver-specific intermediary metabolic enzyme alanine glyoxylate aminotransferase. The prognosis of this metabolic disease is poor. Theoretically, the primary metabolic defect can be cured by liver transplantation. However, controversy exists around the age and stage of the disease that liver transplantation should be performed. We report on a patient who presented at the early age of 2 months with nephrocalcinosis. Isolated liver transplantation was performed at the age of 21 months. Eight years later, the estimated glomerular filtration rate was 85 ml/min/1.73 m(2), and imaging studies did not reveal nephrocalcinosis. This case report supports the strategy of early isolated liver transplantation in patients with PH-1.


Assuntos
Hiperoxalúria Primária/cirurgia , Transplante de Fígado/métodos , Nefrocalcinose/complicações , Criança , Consanguinidade , Seguimentos , Taxa de Filtração Glomerular , Humanos , Hiperoxalúria Primária/complicações , Hiperoxalúria Primária/metabolismo , Lactente , Transplante de Fígado/efeitos adversos , Masculino , Nefrocalcinose/cirurgia , Prognóstico , Resultado do Tratamento
4.
Clin J Am Soc Nephrol ; 12(1): 105-112, 2017 01 06.
Artigo em Inglês | MEDLINE | ID: mdl-27899416

RESUMO

BACKGROUND AND OBJECTIVES: Little published information is available about access failure in children undergoing chronic peritoneal dialysis. Our objectives were to evaluate frequency, risk factors, interventions, and outcome of peritoneal dialysis access revision. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Data were derived from 824 incident and 1629 prevalent patients from 105 pediatric nephrology centers enrolled in the International Pediatric Peritoneal Dialysis Network Registry between 2007 and 2015. RESULTS: In total, 452 access revisions were recorded in 321 (13%) of 2453 patients over 3134 patient-years of follow-up, resulting in an overall access revision rate of 0.14 per treatment year. Among 824 incident patients, 186 (22.6%) underwent 188 access revisions over 1066 patient-years, yielding an access revision rate of 0.17 per treatment year; 83% of access revisions in incident patients were reported within the first year of peritoneal dialysis treatment. Catheter survival rates in incident patients were 84%, 80%, 77%, and 73% at 12, 24, 36, and 48 months, respectively. By multivariate logistic regression analysis, risk of access revision was associated with younger age (odds ratio, 0.93; 95% confidence interval, 0.92 to 0.95; P<0.001), diagnosis of congenital anomalies of the kidney and urinary tract (odds ratio, 1.28; 95% confidence interval, 1.03 to 1.59; P=0.02), coexisting ostomies (odds ratio, 1.42; 95% confidence interval, 1.07 to 1.87; P=0.01), presence of swan neck tunnel with curled intraperitoneal portion (odds ratio, 1.30; 95% confidence interval, 1.04 to 1.63; P=0.02), and high gross national income (odds ratio, 1.10; 95% confidence interval, 1.02 to 1.19; P=0.01). Main reasons for access revisions included mechanical malfunction (60%), peritonitis (16%), exit site infection (12%), and leakage (6%). Need for access revision increased the risk of peritoneal dialysis technique failure or death (hazard ratio, 1.35; 95% confidence interval, 1.10 to 1.65; P=0.003). Access dysfunction due to mechanical causes doubled the risk of technique failure compared with infectious causes (hazard ratio, 1.95; 95% confidence interval, 1.20 to 2.30; P=0.03). CONCLUSIONS: Peritoneal dialysis catheter revisions are common in pediatric patients on peritoneal dialysis and complicate provision of chronic peritoneal dialysis. Attention to potentially modifiable risk factors by pediatric nephrologists and pediatric surgeons should be encouraged.


Assuntos
Cateterismo/estatística & dados numéricos , Cateteres de Demora/efeitos adversos , Diálise Peritoneal/estatística & dados numéricos , Reoperação/estatística & dados numéricos , Fatores Etários , Cateterismo/efeitos adversos , Criança , Pré-Escolar , Falha de Equipamento/estatística & dados numéricos , Feminino , Seguimentos , Humanos , Lactente , Infecções/complicações , Rim/anormalidades , Masculino , Estomia/estatística & dados numéricos , Diálise Peritoneal/efeitos adversos , Diálise Peritoneal/instrumentação , Peritonite/complicações
5.
Clin J Am Soc Nephrol ; 10(4): 592-600, 2015 Apr 07.
Artigo em Inglês | MEDLINE | ID: mdl-25635037

RESUMO

BACKGROUND AND OBJECTIVES: Steroid-resistant nephrotic syndrome is a rare kidney disease involving either immune-mediated or genetic alterations of podocyte structure and function. The rare nature, heterogeneity, and slow evolution of the disorder are major obstacles to systematic genotype-phenotype, intervention, and outcome studies, hampering the development of evidence-based diagnostic and therapeutic concepts. To overcome these limitations, the PodoNet Consortium has created an international registry for congenital nephrotic syndrome and childhood-onset steroid-resistant nephrotic syndrome. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Since August of 2009, clinical, biochemical, genetic, and histopathologic information was collected both retrospectively and prospectively from 1655 patients with childhood-onset steroid-resistant nephrotic syndrome, congenital nephrotic syndrome, or persistent subnephrotic proteinuria of likely genetic origin at 67 centers in 21 countries through an online portal. RESULTS: Steroid-resistant nephrotic syndrome manifested in the first 5 years of life in 64% of the patients. Congenital nephrotic syndrome accounted for 6% of all patients. Extrarenal abnormalities were reported in 17% of patients. The most common histopathologic diagnoses were FSGS (56%), minimal change nephropathy (21%), and mesangioproliferative GN (12%). Mutation screening was performed in 1174 patients, and a genetic disease cause was identified in 23.6% of the screened patients. Among 14 genes with reported mutations, abnormalities in NPHS2 (n=138), WT1 (n=48), and NPHS1 (n=41) were most commonly identified. The proportion of patients with a genetic disease cause decreased with increasing manifestation age: from 66% in congenital nephrotic syndrome to 15%-16% in schoolchildren and adolescents. Among various intensified immunosuppressive therapy protocols, calcineurin inhibitors and rituximab yielded consistently high response rates, with 40%-45% of patients achieving complete remission. Confirmation of a genetic diagnosis but not the histopathologic disease type was strongly predictive of intensified immunosuppressive therapy responsiveness. Post-transplant disease recurrence was noted in 25.8% of patients without compared with 4.5% (n=4) of patients with a genetic diagnosis. CONCLUSIONS: The PodoNet cohort may serve as a source of reference for future clinical and genetic research in this rare but significant kidney disease.


Assuntos
Glomerulonefrite Membranoproliferativa , Glomerulosclerose Segmentar e Focal , Nefrose Lipoide , Síndrome Nefrótica/congênito , Adolescente , Distribuição por Idade , Idade de Início , Biópsia , Criança , Pré-Escolar , Análise Mutacional de DNA , Europa (Continente)/epidemiologia , Feminino , Marcadores Genéticos , Predisposição Genética para Doença , Glomerulonefrite Membranoproliferativa/diagnóstico , Glomerulonefrite Membranoproliferativa/epidemiologia , Glomerulonefrite Membranoproliferativa/genética , Glomerulonefrite Membranoproliferativa/terapia , Glomerulosclerose Segmentar e Focal/diagnóstico , Glomerulosclerose Segmentar e Focal/epidemiologia , Glomerulosclerose Segmentar e Focal/genética , Glomerulosclerose Segmentar e Focal/terapia , Humanos , Imunossupressores/uso terapêutico , Lactente , Recém-Nascido , Transplante de Rim , América Latina/epidemiologia , Masculino , Oriente Médio/epidemiologia , Mutação , Nefrose Lipoide/diagnóstico , Nefrose Lipoide/epidemiologia , Nefrose Lipoide/genética , Nefrose Lipoide/terapia , Síndrome Nefrótica/diagnóstico , Síndrome Nefrótica/epidemiologia , Síndrome Nefrótica/genética , Síndrome Nefrótica/terapia , Fenótipo , Estudos Prospectivos , Recidiva , Sistema de Registros , Indução de Remissão , Estudos Retrospectivos , Fatores de Risco , Resultado do Tratamento , Adulto Jovem
6.
Perinatol. reprod ; 3(1): 4-9, 1990. tab
Artigo em Espanhol | LILACS | ID: lil-96594

RESUMO

Se estudian factores propios del adolescente escolar, determinantes de práctica sexual precoz. La investigación se realizó en dos colegios del área oriente de Santiago, a través de una encuesta anónima a un total de 609 alumnos de enseñanza media. El sexo, fuentes de enseñanza en reproducción y sexualidad, nivel de conocimientos en sexualidad y la percepción de la educación sexual recibida, aparecen como variables relacionadas con experiencia coital en la población estudiada


Assuntos
Adolescente , Humanos , Masculino , Feminino , Comportamento do Adolescente , Sexo , Comportamento Sexual , Conhecimentos, Atitudes e Prática em Saúde , Estudantes
7.
Prensa méd. argent ; 73(15): 662-4, 3 oct. 1986. ilus
Artigo em Espanhol | LILACS | ID: lil-45667

RESUMO

Se describen dos observaciones de cordoma de la región sacrocoxígea (un varón y una mujer). Los estudios realizados, incluidos T.C., fueron completos; en un caso se efectuó la necropsia. Se hace referencia a la historia del tumor, su clínica más común y su tratamiento paliativo


Assuntos
Pessoa de Meia-Idade , Humanos , Masculino , Feminino , Cordoma/patologia , Região Sacrococcígea/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA